Male Wistar rats were used to evaluate microvenous prosthetic grafting techniques and microvenous prostheses in the femoral vein. With the end-to-end technique to implant microvenous prostheses, there was extensive exposure of vessel wall collagen especially at the suture sites. Thrombus formation then led to complete occlusion in all but one of the 32 prostheses 60 min after implantation. However, with the sleeve anastomotic technique there was only minimal exposure of collagen and minimal thrombus accumulation. Fifty-nine of the 64 microvenous prostheses implanted with the sleeve technique were patent after 1 day, 1,3,6, and 12 weeks (patency rate 921170). All patent microvenous prostheses were completely covered by an endothelial layer after 3 weeks. It was concluded that the rat is an appropriate experimental laboratory animal for evaluating new grafting techniques with microvenous prostheses and that the sleeve anastomotic technique gives the highest patency rates with microvenous prostheses.
or replantations, and so it would be advantageous to have reliable synthetic microvascular prostheses of various sizes readily available. Thus far, both clinical and experimental replacements of microvenous segments with prosthetic conduits have been largely unsuccessful due to thrombosis. Several factors are thought to be responsible such as the thrombogenicity of the graft material and the low flow rate (Hiratzka & Wright, 1978;  Kunlin & Kunlin, 1979; Gloviczki et at., 1984) .
There has been only one successful report of a synthetic venous graft in the peripheral venous system in humans (Tachakra & Smith, 1977) . In animals too most synthetic prostheses occlude due to thrombotic events, thus Parsa and Spira (1979) found that all microvenous PTFE prostheses thrombosed within 15 min after implantation into the rat femoral vein. Cuadros and Hughes (1986) found that only by creating a temporary arteriovenous fistula did they succeed in achieving 1001170 patency rate. However, producing a temporary arteriovenous fistula is time consuming and not very suitable for microsurgical use. Therefore, there remains a need for a more successful and reliable way of prosthetic venous grafting.
In a pilot study, Lauritzen (1983) found a 50070 patency rate when implanting rigid microvenous prostheses with the sleeve anastomotic technique ( Fig. 1 ). We confirmed this and also demonstrated that thrombus formation starts at the site of the anastomoses in areas of 'unavoidable' surgical trauma when implanting microvenous prostheses by means of the conventional end-to-end anastomotic technique with interrupted sutures. Therefore we developed further the sleeve anastomotic technique in the rat to produce a more successful way of implanting microvenous Fig. 1 . Schematic drawing of the sleeve anastomotic implantation technique; the vein (V) is slipped over the end of the prosthesis (P) and fixed by means of a circumferentially placed suture (8). (From van der Lei et al., 1991a, with permission.) prostheses (Robinson et al., 1989; 1990; van der Lei et al., 1991a; 1991b) . Our earlier experience had shown the rat can provide a good experimental model (Bartels & van der Lei, 1988) and the aim of this report is to describe our experiences with prosthetic microvenous grafting techniques and microvenous prostheses in the rat femoral vein.
polyurethane-based (PU) material or PTFE (Gore-Tex; W. L. Gore & Associates, Arizona, USA) were implanted, either by a standard endto-end anastomotic technique using interrupted sutures (Bartels & van der Lei, 1988) , or by the sleeve anastomotique technique (Fig. 1) , depending on the experiments planned (see Tables 1 & 2). Both types of prostheses had a length of 5-7 mm and an internal diameter of 1mm and the suture used was Ethilon 1% nylon BV-4 needle (chord 4 mm, diameter 100 !tm) (Ethilon Inc.). After accomplishing the anastomoses, O· 2-0' 5 ml 2% lidocaine was applied topically to relieve spasm and then the clamps were removed. The femoral vein cross-clamping time ranged from 17 to 30 min. Neither anticoagulants nor antiplatelet agents were used. The animals were housed individually and received commercial pelletted diet (RMH-B 10mm, Hope Farms, Woerden, The Netherlands) and water ad libitum.
Surgical exposure of the femoral vein
The rats were premedicated with atropine (0' 25 mg/kg body weight administered subcutaneously). Anaesthesia was induced using a 1:2 mixture of 02/N20 at a flow rate of 600 ml/min, with 4% halothane (Fluothane) via a conical face mask. After successful induction, anaesthesia was maintained with 1070 halothane. Under sterile conditions and disinfection with 10% povidine-iodine solution, the femoral triangle was incised along the inguinal fold and by use of an operation microscope (Zeiss OPMI 6-SD, Carl Zeiss Inc., Germany) the femoral vein was carefully exposed.
Implantation of microvenous prostheses
Microvenous prostheses, prepared from either a
Graft harvesting
The microvenous prostheses were harvested from 1min to 12 weeks after implantation, depending upon the experiments planned (see Tables 1& 2) . Graft patency was then determined by direct inspection and the prosthesis was removed, flushed with saline solution, fixed in 2070 phosphatebuffered glutaraldehyde, and subsequently prepared for, and examined by, routine scanning electron microscopy (van der Lei et al., 1987) .
Results and discussion Thrombotic events after end-to-end anastomotic technique
Initially all prostheses were patent upon release of the clamps. At the site of anastomosis there was destruction of the endothelial layer , which normally forms the natural antithrombogenic lining of the vascular system by producing PGl2
Bartels, van der Lei & Robinson (Moncada et al., 1977) . At the suture sites especially, there was extensive exposure of the collagen of the vessel wall and thrombus formation started here ( Fig. 2a,b ) and increased with increasing postoperative time intervals (Fig.  2c,d) , leading to occlusion of all but one of the 32 microvenous prostheses after 60 min of implantation (see Table 1 ).
Thrombotic events after sleeve anastomotic technique
In the initial series of experiments, 6 of the 8 PU prostheses and all 4 PTFE prostheses were patent (see Table 2 ) and showed only minimal exposure of collagenous tissue at the anastomotic sites and minimal thrombus accumulation (Fig. 3 ). Therefore, we extended our experiments with both PU and PTFE prostheses for longer periods of implantation (Table 2) . 
Patency and repair of micro venous prostheses implanted with sleeve anastomotic technique
Most of the PU and PTFE prostheses implanted by means of the sleeve anastomotic technique and evaluated after I day, 1,3,6, and 12 weeks were patent (59 of the 64 prostheses; patency rate 92OJo). The patent PU and PTFE microvenous prostheses were already covered by a complete endothelial layer after 3 weeks (Fig. 4a,b,c) . This indicates a venous endothelial growth rate of at b ..• ·S&T 10/0 nylon, needle with chord length of 3 mm and a diameter of 70~m. PU = Polyurethane-based; PTFE-polytetrafluoroethylene. Table 3 . End-to-end anastomotic technique with finer needle. Patency of \·0 mm microvenous prostheses implanted by means of the end-to-end anastomotic technique into the rat femoral vein, using a finer needle· compared with the experiments shown in Table I .
Successful end-to-end technique with finer needle
After the initial series of experiments with PU and PTFE prostheses implanted by means of the conventional end-to-end suture technique, in least 0·125 nun/day, but probably is much higher. Ishimaru et al. (1981) estimated the growth rate of venous endothelium to be 0,3-0'5 mm/day in an expanded PTFE graft implanted in the canine caudal vena cava. At 6 and 12 weeks after implantation, both types of prostheses still had an inner endothelial lining (Fig. 5) .
which all but one of the 32 prostheses were occluded after 60 min of implantation (see Table 1 ; patency rate 3070),we recently have performed an additional series of implantations with the conventional end-to-end technique with suture (l0/0 nylon, S&T, Swiss) with a finer needle (chord length 3 mm, diameter 70 J.tm)(see Table 3 ). All 10 implanted PU prostheses were occluded after 1 day, but 8 of the 10 PTFE prostheses were patent. The patent PTFE prostheses in this series of experiments showed a healing pattern similar to those prostheses implanted by means of the sleeve technique ( Fig.  6a,b ). Whether the suture with the finer needle or our gaining experience is responsible for the higher patency rate with the end-to-end technique has not yet been ascertained, but this has to be tested in a prospective study comparing both type of sutures in one model (a study is now underway). The reason why the conventional end-to-end suture technique seems to be more successful with PTFE prostheses than with the PU prostheses may be the result of the relative ease of coaptation of the thinner-walled PTFE prosthesis to the vein wall together with the more (5) is covered with endothelium; (b) also in the mid-region the prosthesis is already covered with endothelium.
anti-thrombogenic characteristics of PTFE (van der Lei & Wildevuur, 1988; 1989) .
Conclusions
It is concluded that the rat is an appropriate experimental laboratory animal for evaluating new prosthetic microvenous grafting techniques and microvenous prostheses. The sleeve anastomotic technique seems to improve the patency rate with microvenous prostheses, possibly as this technique prevents extensive exposure of collagenous vessel wall tissue at the site of anastomosis. Alternatively the use of a finer needle and/or the use of antithrombotic coatings might improve patency rates using the
